Clinical investigation of halopredone acetate, a new topical steroid, in dermatology. Controlled study
- PMID:341905
Clinical investigation of halopredone acetate, a new topical steroid, in dermatology. Controlled study
Abstract
17,21-Bis(acetyloxy)-2-bromo-6beta,9-difluoro-11beta-hydroxypregna-1,4-diene-3,20-dione (halopredone acetate; Topicon) cream, a new synthetic corticosteroid for topical use, has been evaluated against betamethasone valerate by means of double-blind sequential study, where the patients, mainly affected with psoriasis, presented symmetrically located lesions which were treated with either the new drug or the reference cream so that each patient could serve as his own control. Activity and tolerability of the two preparations were equivalent. This equivalence is particularly significant when bearing in mind that the concentration of the active principle (0.01%) contained in the halopredone acetate cream is one of the lowest employed so far and 10 times lower than that of the reference steroid (betamethasone valerate 0.1%). A second open trial, made in 30 patients suffering from psoriasis, confirmed the positive anti-inflammatory properties which the new substance had already displayed during the previous pharmacological tests.
Similar articles
- Preliminary clinical evaluation of a new topical corticosteroid, halopredone acetate, as compared to fluocinonide.Rampini E, Rastelli A, Divano C.Rampini E, et al.Arzneimittelforschung. 1977;27(12):2396-9.Arzneimittelforschung. 1977.PMID:341903Clinical Trial.
- Clinical study of the relationship between dose and response to halopredone acetate in dermatoses.Rampini E, Rastelli A, Divano C.Rampini E, et al.Arzneimittelforschung. 1977;27(12):2399-403.Arzneimittelforschung. 1977.PMID:341904Clinical Trial.
- Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.Molin L, Cutler TP, Helander I, Nyfors B, Downes N.Molin L, et al.Br J Dermatol. 1997 Jan;136(1):89-93.Br J Dermatol. 1997.PMID:9039301Clinical Trial.
- Pharmacology of halopredone acetate, a new topical antiinflammatory steroid.Bianchetti A, Bossoni G, Guarneri L, Giudici L, Riva M.Bianchetti A, et al.Arzneimittelforschung. 1977;27(11):2096-102.Arzneimittelforschung. 1977.PMID:580007
- New dermatological agents for the treatment of psoriasis.Thacher SM, Vasudevan J, Tsang KY, Nagpal S, Chandraratna RA.Thacher SM, et al.J Med Chem. 2001 Feb 1;44(3):281-97. doi: 10.1021/jm0000214.J Med Chem. 2001.PMID:11462969Review.No abstract available.
Cited by
- Strategies for using topical corticosteroids in children and adults with eczema.Lax SJ, Harvey J, Axon E, Howells L, Santer M, Ridd MJ, Lawton S, Langan S, Roberts A, Ahmed A, Muller I, Ming LC, Panda S, Chernyshov P, Carter B, Williams HC, Thomas KS, Chalmers JR.Lax SJ, et al.Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013356. doi: 10.1002/14651858.CD013356.pub2.Cochrane Database Syst Rev. 2022.PMID:35275399Free PMC article.Review.
- Comparative study of the vasoconstrictor activity of halopredone acetate in a modified McKenzie test.Rampini E, Rastelli A, Cardo P.Rampini E, et al.Eur J Clin Pharmacol. 1978 Dec 18;14(5):325-9. doi: 10.1007/BF00611901.Eur J Clin Pharmacol. 1978.PMID:729625
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Miscellaneous